Zobrazeno 1 - 10 of 179 pro vyhledávání: '"van der Zee AGJ"'
1
Akademický článek
Immunologic aspect of ovarian cancer and p53 as tumor antigen
Autor: van der Burg SH, Lambeck A, Nijman HW, van der Zee AGJ, Daemen T
Publikováno v: Journal of Translational Medicine, Vol 3, Iss 1, p 34 (2005)
Abstract Ovarian cancer represents the fifth leading cause of death from all cancers for women. During the last decades overall survival has improved due to the use of new chemotherapy schedules. Still, the majority of patients die of this disease. R
Externí odkaz: https://doaj.org/article/0e57f521a2354b6b801fb8a7df051c22
Zobrazit plný text záznamu
2
Akademický článek
The efficacy of ultrasound in the follow up after a negative sentinel lymph node in women with vulvar cancer: a prospective single-centre study.
Autor: Pouwer, A. W., Mus, R. D. M., IntHout, J., van der Zee, A. G. J., Bulten, J., Massuger, L. F. A. G., de Hullu, J. A., Mus, Rdm, van der Zee, Agj, Massuger, Lfag
Publikováno v: BJOG: An International Journal of Obstetrics & Gynaecology; Oct2018, Vol. 125 Issue 11, p1461-1468, 8p, 1 Color Photograph, 1 Diagram, 3 Charts, 1 Graph
Zobrazit plný text záznamu
3
Development of a radioiodinated apoptosis–inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies
Autor: Duiker, EW, Dijkers, ECF, Lambers Heerspink, H, de Jong, S, van der Zee, AGJ, Jager, PL, Kosterink, JGW, de Vries, EGE, Lub-de Hooge, MN
The TNF-related apoptosis inducing ligand (TRAIL) induces apoptosis through activation of the death receptors, TRAIL-R1 and TRAIL-R2. Recombinant human (rh) TRAIL and the TRAIL-R1 directed monoclonal antibody mapatumumab are currently clinically eval
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::199b0085992e6c3494cedb87cd214523
https://europepmc.org/articles/PMC3413857/
Zobrazit plný text záznamu
6
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis
Autor: Hougardy, BMT, Maduro, JH, van der Zee, AGJ, de Groot, DJA, van den Heuvel, FAJ, de Vries, EGE, de Jong, S
Publikováno v: International Journal of Cancer, 118(8), 1892-1900. Wiley
In cervical carcinogenesis, the p53 tumor suppressor pathway is disrupted by HPV (human papilloma virus) E6 oncogene expression. E6 targets p53 for rapid proteasome-mediated degradation. We therefore investigated whether proteasome inhibition by MG13
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::a0433cbddf539b9e7cc589da7ca0767d
https://research.rug.nl/en/publications/f7098733-5245-4567-8496-d44a304e008c
Zobrazit plný text záznamu
7
Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?
Autor: Jongen, VHWM, Thijssen, JHH, Hollema, H, Donker, GH, Santema, JG, Van Der Zee, AGJ, Heineman, MJ
Publikováno v: International Journal of Gynecological Cancer, 15(3), 529-536. LIPPINCOTT WILLIAMS & WILKINS
Prospectively, the relationship between androgen levels in the utero-ovarian circulation, aromatase activity in endometrial and body fat tissue, and the presence or absence of endometrioid endometrial cancer was studied in postmenopausal women. In 43
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::c2a5e537c489e62fafd7f33355b6a385
https://research.rug.nl/en/publications/d17cfc0f-4fcc-4056-9be8-276ca1193f99
Zobrazit plný text záznamu
8
Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivity
Autor: Van Dillen, IJ, Mulder, NH, Meijer, C, Dam, WA, Kamstra, E, De Vries, L, Meersma, GJ, Van Der Zee, AGJ, De Vries, EFJ, Vaalburg, W, Hospers, GAP
Publikováno v: Journal of chemotherapy, 17(3), 289-296
Our study focused on the influence of herpes simplex virus thymidine kinase (HSV-tk) expression and ganciclovir (GCV) treatment on the sensitivity of C6 glioma cells to frequently used chemotherapeutic drugs, i.e. adriamycin (ADR), cisplatin (CDDP),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d169f9b358ec979ce78f53fc88b20f29
https://www.bib.irb.hr/273065
Zobrazit plný text záznamu
10
Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy: cardiovascular risk factors and signs of vascular damage
Autor: de Vos, FYFL, Nuver, J, Willemse, PHB, van der Zee, AGJ, Messerschraidt, J, Burgerhof, JGM, de Vries, EGE, Gietema, JA
Publikováno v: European Journal of Cancer, 40(5), 696-700. ELSEVIER SCI LTD
dMale germ cell tumour patients treated with cisplatin-based chemotherapy frequently develop cardiovascular risk factors and disease, but sparse information is available about long-term complications of this type of chemotherapy in women. We investig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::235274760ab72ac546653b8551c46835
https://research.rug.nl/en/publications/9d148e58-0449-481d-8d80-637a4bee95a4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje